ASCO 2022: Drug combination shows promise against cancer’s ‘death star’ protein 03 Jun 2022 A drug combination targeting multiple mutant versions of cancer’s ‘death star’ protein has shown promise in a small, early-phase clinical trial for some patients with advanced lung, ovarian and thyroid cancer. Find out more Show/Hide
Scientists use AI to identify new drug combination for children with incurable brain cancer 22 Sep 2021 Scientists have used artificial intelligence-enhanced tools to successfully propose a new combination of drugs for use against an incurable childhood brain cancer. Find out more Show/Hide